Ami Organics - Pharma Intermediates & Specialty Chemicals

JM_Financial_Initiating_Coverage_on_Ami_Organics_with_29%_UPSIDE.pdf (2.7 MB)

1 Like

AMI Organics | Management Guidance

Results Update
Strong Growth in Q3FY25:
Revenue: ₹2,750 Mn (+65.2% YoY)
EBITDA: ₹687 Mn (+159% YoY)
PAT: ₹454 Mn (+155.1% YoY)

CDMO Business Expansion:
a. Significant ramp-up in the Contract Development & Manufacturing (CDMO) segment.
b. Several CDMO projects progressing toward commercialization by FY26.
c. Positive discussions with innovators & partners for future growth.

Revised FY25 Growth Guidance:
Growth guidance revised upward from 30% to 35% due to strong Q3 performance

9 Likes

hey Amit , thanks for sharing and its great report, how do you get access to such reports?

This telegram channel.

2 Likes

KUDOS! thank you! keep sharing !